Jasper Therapeutics (JSPR) announced the appointment of two seasoned pharma industry executives to its regulatory affairs, quality and clinical operations leadership teams. Patricia Carlos joins Jasper as the company’s Senior Vice President, SVP, of Regulatory Affairs and Quality, and Annette Marcantonio was appointed as Vice President, VP, of Clinical Operations. Prior to joining Jasper, Carlos was Chief Regulatory, Quality and Safety Officer at Agenus (AGEN). Prior to joining Jasper, Marcantonio served as VP of Clinical Operations at Pacylex Pharmaceuticals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on JSPR:
- Jasper announces first patient dosed in Phase 1 trial of briquilimab
- Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors
- Jasper Therapeutics ap0points Brun to board of directors
- Jasper Therapeutics appoints Edwin Tucker as CMO
Questions or Comments about the article? Write to editor@tipranks.com